FDA Adverse Event Injury Summary report: N

BIZACT

MDR report key: 12273585 · Received August 4, 2021

Report

Report Number
1717344-2021-01093
Event Type
Injury
Date Received
August 4, 2021
Date of Event
May 7, 2021
Report Date
August 4, 2021
Manufacturer
COVIDIEN MFG DC BOULDER
Product Code
GEI
UDI-DI
10884521552456
PMA / PMN Number
K160539
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
AS
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

TITLE: HEALTH RELATED QUALITY OF LIFE T-14 OUTCOMES FOR PEDIATRIC BIZACT TONSILLECTOMY SOURCE: MEDICINA 2021, 57, 480 PP.1-8. IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

ACCORDING TO LITERATURE SOURCE OF STUDY PERFORMED BETWEEN JULY 2016 AND OCTOBER 2019, A STUDY EVALUATED PEDIATRIC PATIENTS (AGE 1-16) WHO UNDERWENT TONSILLECTOMY USING BIZACT. THERE WERE 146 PATIENTS AND COMPLICATIONS INCLUDED: POST-TONSILLECTOMY HEMORRHAGE AND INFECTION. THREE PATIENTS REQUIRED REOPERATION FOR BLEEDING AND HOSPITAL ADMISSION WAS REQUIRED FOR INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1173749 BIZACT ELECTROSURGICAL, CUTTING & COAGULATION & ACCES GEI COVIDIEN MFG DC BOULDER BZ4112- 10884521552456

Patients

Seq Age Sex Outcome Treatment
1 5 YR Required Intervention